Technical Analysis for VYGR - Voyager Therapeutics, Inc.

Grade Last Price % Change Price Change
F 4.56 6.29% 0.27
VYGR closed up 6.29 percent on Friday, May 14, 2021, on 58 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical VYGR trend table...

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
Inside Day Range Contraction 0.00%
20 DMA Resistance Bearish 6.29%
Bearish Engulfing Bearish 6.29%
Oversold Stochastic Weakness 6.29%
20 DMA Resistance Bearish 2.01%
Oversold Stochastic Weakness 2.01%
Slingshot Bearish Bearish Swing Setup 3.64%
Bullish Engulfing Bullish 3.64%
Lower Bollinger Band Walk Weakness 3.64%
Older End-of-Day Signals for VYGR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day 2 days ago
Up 5% 2 days ago
60 Minute Opening Range Breakout 3 days ago
Rose Above 10 DMA 3 days ago
Up 3% 3 days ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Voyager Therapeutics, Inc. Description

Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe diseases of the central nervous system (CNS). The company focuses in the field of adeno-associated virus gene therapy through innovation and investment in vector engineering and optimization, manufacturing, and dosing and delivery techniques. Its pipeline includes VY-AADC01, which is in Phase 1b clinical trials for treatment of Parkinson's disease; and preclinical programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis, VY-FXN01 for Friedreich's ataxia, and VY-HTT01 for Huntington's disease, as well as VY-SMN101 for neuromuscular disease. The company has strategic collaborations with Genzyme Corporation and the University of Massachusetts Medical School. Voyager Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Genetics Gene Therapy Parkinson's Disease Amyotrophic Lateral Sclerosis Treatment Of Parkinson's Disease Huntington's Disease Genzyme Monogenic Ataxia Friedreich's Ataxia Neuromuscular Disease Severe Diseases

Is VYGR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.62
52 Week Low 3.9
Average Volume 594,020
200-Day Moving Average 8.36
50-Day Moving Average 4.92
20-Day Moving Average 4.63
10-Day Moving Average 4.39
Average True Range 0.35
ADX 19.01
+DI 20.32
-DI 21.18
Chandelier Exit (Long, 3 ATRs ) 4.91
Chandelier Exit (Short, 3 ATRs ) 4.96
Upper Bollinger Band 5.27
Lower Bollinger Band 3.99
Percent B (%b) 0.45
BandWidth 27.54
MACD Line -0.18
MACD Signal Line -0.19
MACD Histogram 0.0071
Fundamentals Value
Market Cap 170.69 Million
Num Shares 37.4 Million
EPS 1.07
Price-to-Earnings (P/E) Ratio 4.27
Price-to-Sales 1.55
Price-to-Book 1.85
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.00
Resistance 3 (R3) 4.95 4.77 4.92
Resistance 2 (R2) 4.77 4.66 4.79 4.90
Resistance 1 (R1) 4.66 4.59 4.72 4.71 4.87
Pivot Point 4.48 4.48 4.50 4.50 4.48
Support 1 (S1) 4.37 4.37 4.43 4.42 4.25
Support 2 (S2) 4.19 4.30 4.21 4.22
Support 3 (S3) 4.08 4.19 4.20
Support 4 (S4) 4.13